C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2009
11/12/2009	US20090281041 Antiviral cell-penetrating peptides
11/12/2009	US20090281036 Fusion peptide for inhibiting interaction of neuronal nmda receptor (nmdar) and nmdar interacting proteins
11/12/2009	US20090281035 Soluble Heterodimeric Receptors and Uses Thereof
11/12/2009	US20090281031 Methods and Compositions Related to Improving Properties of Pharmacological Agents Targeting Nervous System
11/12/2009	US20090281029 Lactoferrin complex and method of producing the same
11/12/2009	US20090281028 OSK1 peptide analogs and pharmaceutical compositions
11/12/2009	US20090281027 Modified vitamin k-dependent polypeptides
11/12/2009	US20090281024 Compositions Comprising Receptor-Associated Protein (RAP) Variants Specific for CR-Containing Proteins and Uses Thereof
11/12/2009	US20090281022 Method for Producing Factor VII Glycoforms
11/12/2009	US20090280562 Materials and methods for preparing dimeric growth factors
11/12/2009	US20090280561 Fusion protein of hiv regulatory/accessory proteins
11/12/2009	US20090280560 Yeast cell surface display of proteins and uses thereof
11/12/2009	US20090280555 Enzyme treatment of foodstuffs for celiac sprue
11/12/2009	US20090280554 Modified vitamin k-dependent polypeptides
11/12/2009	US20090280533 Serum-free mammalian cell culture medium, and uses thereof
11/12/2009	US20090280532 Serum-free mammalian cell culture medium, and uses thereof
11/12/2009	US20090280530 Novel collagen-like protein clac, precursor thereof and genes encoding the same
11/12/2009	US20090280512 Tumor marker for renal cancer and method for determination of occurrence of renal cancer
11/12/2009	US20090280506 Sf, a novel family of taste receptors
11/12/2009	US20090280499 Method and kit for detecting, or determining 3,4- methylenedioxymethamphetamine
11/12/2009	US20090280495 tyrosine kinase proteins, inhibitors; kits
11/12/2009	US20090280488 Prophylactic/therapeutic agent for neurodegenerative disease
11/12/2009	US20090280487 Methods for producing olfactory gpcrs
11/12/2009	US20090280482 Novel nucleic acid sequences encoding adenylate kinases, alcohol dehydrogenases, ubiquitin proteases, lipases, adenylate cyclases, and GTPase activators
11/12/2009	US20090280480 Devices from Prion-Like Proteins
11/12/2009	US20090280473 Inhibition of membrane fusion proteins
11/12/2009	US20090280455 Interactive dental restorative network
11/12/2009	US20090280190 Anti-angiogenic peptides from the n-terminus of endostatin
11/12/2009	US20090280168 Chlamydia polypeptides used to prevent, treat, and diagnose Chlamydia infection; 98 KDa OMP antigen designated CPN100686 RY 54
11/12/2009	US20090280165 Compounds that bind alpha5beta1 integrin and methods of use
11/12/2009	US20090280161 Thin Film Multilocular Structure Made of Collagen, Member for Tissue Regeneration Containing The Same, and Method for Producing The Same
11/12/2009	US20090280145 Adjuvant viral particle
11/12/2009	US20090280144 Recombinant newcastle disease virus RNA expression systems and vaccines
11/12/2009	US20090280141 Streptococcal Genes
11/12/2009	US20090280126 biological fragments comprising polypeptides, in a combination with phosphatides, used for for immunization or treatment of ischemic cardiovascular disorders, in humans
11/12/2009	US20090280125 Prion epitopes and methods of use thereof
11/12/2009	US20090280110 Cell Model for Alzheimer's Disease Pathology
11/12/2009	US20090280107 Modified vitamin k-dependent polypeptides
11/12/2009	US20090280106 Pituitary adenylate cyclase acivating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use
11/12/2009	US20090280092 G-Protein Coupled Receptor 83 As a Molecular Switch for the Induction of Regulatory (immunosuppressive) T-cells
11/12/2009	US20090280085 Long Acting Human Interferon Analogs
11/12/2009	CA2758834A1 Primary cell derived biologic modified manufacturing process
11/12/2009	CA2757513A1 Modified stefin a scaffold proteins
11/12/2009	CA2725227A1 Antiviral cell penetrating peptides
11/12/2009	CA2725208A1 Methods and compositions for inducing brown adipogenesis
11/12/2009	CA2723698A1 Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis
11/12/2009	CA2723412A1 Lysosomal targeting peptides and uses thereof
11/12/2009	CA2722821A1 Colostrum-derived fraction for wound healing and skin care
11/12/2009	CA2722806A1 Plants having enhanced yield-related traits and a method for making the same
11/12/2009	CA2722474A1 Anti-angiogenic compounds
11/12/2009	CA2722127A1 Compositions and methods for inhibiting shiga toxin and shiga-like toxin
11/12/2009	CA2721683A1 Modified factor ix polypeptides and uses thereof
11/12/2009	CA2720685A1 Affinity matured crig variants
11/12/2009	CA2712103A1 Transcriptional control in alicyclobacillus acidocaldarius and associated genes, proteins, and methods
11/11/2009	EP2116617A2 Probes, probe sets, methods and kits pertaining to the detection, identification and/or enumeration of bacteria
11/11/2009	EP2116616A2 Genes differentially expressed in activated T cells and uses thereof
11/11/2009	EP2116615A1 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas
11/11/2009	EP2116604A1 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
11/11/2009	EP2116596A1 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them
11/11/2009	EP2116553A1 EML4-ALK fusion gene
11/11/2009	EP2116552A2 Peptides, derivatives thereof, process for producing the same, strain producing the same, and antiviral agent comprising the same as active ingredient
11/11/2009	EP2116551A1 Compositions and methods for the treatment of immune related diseases
11/11/2009	EP2116261A1 Sub-region of a plasmodium protein with improved vaccine potential and medical uses thereof
11/11/2009	EP2116260A1 Screening method for agents suitable for prophylaxis and therapy of Alzheimer's disease (AD)
11/11/2009	EP2116259A1 TACI-immunoglobulin fusion proteins
11/11/2009	EP2116251A1 Antibotic antimicrobial agents and methods of their use
11/11/2009	EP2115465A2 Surgical applications for bmp binding protein
11/11/2009	EP2115156A2 Multimeric elp fusion constructs
11/11/2009	EP2115149A2 Chloroplast transit peptides for efficient targeting of dmo and uses thereof
11/11/2009	EP2115126A1 Use of copper and glutamate in cell culture for production of polypeptides
11/11/2009	EP2115122A2 Expression of hla proteins on non-human cells
11/11/2009	EP2115000A1 Isolation and separation of minimally denatured potato proteins and peptides
11/11/2009	EP2114999A2 Transferrin fusion protein libraries
11/11/2009	EP2114998A1 Novel multimeric molecules, method for preparing same and use thereof in the preparation of drugs
11/11/2009	EP2114997A2 Coding genes with a single exon for new bioactive peptides
11/11/2009	EP2114996A1 Allergen-binding ige monoclonal antibodies and method for preparing hypoallergens
11/11/2009	EP2114995A1 Recombinant malaria vaccine
11/11/2009	EP2114994A1 Proteins activating pro-phenoloxidase system and genes encoding the same
11/11/2009	EP2114993A1 Vaccine
11/11/2009	EP2114992A2 Anti-bacterial peptides and methods of treating diseases using same
11/11/2009	EP2114990A2 Gene and protein expression profiles associated with the therapeutic efficacy of egfr-tk inhibitors
11/11/2009	EP2114989A2 Natural polypeptides for oral health care
11/11/2009	EP2114985A2 Multivariable antigens complexed with targeting humanized monoclonal antibody
11/11/2009	EP2114459A1 Recombinant viral vectors for prevention and protection against alphavirus infection
11/11/2009	EP2114447A1 Prevention and treatment of sub-clinical pcvd
11/11/2009	EP2114445A2 Adenoviral vector-based malaria vaccines
11/11/2009	EP2114437A2 Modified corticotropin releasing factor peptides and uses thereof
11/11/2009	EP2114433A2 Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation
11/11/2009	EP2114429A2 Compositions and methods to prevent cancer with cupredoxins
11/11/2009	EP2114422A1 Osteopontin for the prediction and treatment of cardiovascular diseases
11/11/2009	EP1869066B1 Peptide synthesis of alpha-helixes on peg resin
11/11/2009	EP1702074B1 Prevention of incorporation of non-standard amino acids into protein
11/11/2009	EP1670918B1 Leader sequences for use in production of proteins
11/11/2009	EP1664097B1 Piroplasmid vaccine
11/11/2009	EP1573006B1 Il-21 production in prokaryotic hosts
11/11/2009	EP1498421B1 Gamma-secretase inhibitors
11/11/2009	EP1450856B1 Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use
11/11/2009	EP1372634B1 Use of fumaric acid amides
11/11/2009	EP1317278B1 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
11/11/2009	EP1315812B1 Modified polypeptides stabilized in a desired conformation and methods for producing same

1 ... 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 ... 2916